Updated eligibility: Pneumococcal high-risk pediatric program

Cette information est seulement disponible en anglais.

Advisory Alert

To: Local Health System Partners

July 16, 2025

Eligibility for publicly funded high-risk pediatric pneumococcal vaccine (Pneu-C-20) for children aged 6 weeks to 17 years

Ontario has expanded its publicly funded pneumococcal vaccine program to include high-risk children (aged 17 and under) with specific medical and non-medical conditions that increase their risk of invasive pneumococcal disease (IPD).

Effective immediately

Eligible children who completed their Pneu-C-13 vaccine series may receive one dose of Pneu-C-20.
Children who have already received a pneumococcal series that includes at least one dose of Pneu-C-20 do not need another dose.

Providers may use their current supply of Pneu-C-20 for eligible children. Dose requirements vary by product, age, immunization history, and risk. Please see the fact sheets below for full eligibility details and guidance.

Adult eligibility remains unchanged and is included for convenience.

Contact Public Health Sudbury & Districts

To order a vaccine, please complete the Vaccine Order Form. Email to vaccineorder@phsd.caor fax to 705.677.9616. Report vaccines using the updated reporting form and fax to 705.677.9616 (the form is also available in French).
To report an adverse event following immunization, complete the AEFI reporting form and fax it to 705.677.9616.
For immunization inquiries, call the Vaccine Preventable Diseases program at 705.522.9200, ext. 458 (toll-free 1.866.522.9200).

Sincerely,

Original Signed By

Mustafa Hirji, MD, MPH, FRCPC
Acting Medical Officer of Health and Chief Executive Officer

This item was last modified on July 16, 2025